Peter RossingMD, DMSc
Professor Peter Rossing, MD DMSc, is a clinician researcher devoted to complications in diabetes with focus on renal and cardiovascular complications. He obtained a specialist degree in internal medicine and endocrinology in 2004. Since 2007, he has been a chief physician and manager of the Steno Diabetes Center research team dedicated to the research of micro-and macrovascular complications of diabetes. Since 2012, he is a professor of diabetic angiopathy at University of Copenhagen. Peter Rossing has, in epidemiological studies, investigated key features of the pathophysiology of the diabetic kidney at different stages. He has identified several markers for development of diabetic nephropathy, making it possible to predict the individual risk.
He has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis. He is coordinator of the EU FP7 project PRIORITY aiming to test if urinary proteomics can be used to stratify prevention of renal complications in type 2 diabetes, and the Novo Nordisk Foundation grant PROTON aiming at personalising prevention of diabetic nephropathy. He has co-authored over 300 papers and his h-index is 57. He received the Minkowski prize in 2005 and the Golgi prize in 2016 both from the EASD. He is past president of the Danish Endocrine Society, and of the European Diabetic Nephropathy Study group and chairman of the Danish National Diabetes Registry.